RC

Rajesh Choudhary

Active Director Director DIN 07427597
DIN 07427597 First appointment Feb 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2016
Shareholding value •••• Premium profile

About Rajesh Choudhary

Data last updated:

Rajesh Choudhary is a Director at Hawitt Pharmaceuticals Private Limited (since 2016). The company operates in Pharma. Hawitt Pharmaceuticals Private Limited reported revenue of ₹1.48 Cr (FY 2025).

DIN 07427597
Primary Designation Director
Industry Pharma
First Appointment 10 Feb 2016
Oldest Company Age 10 yrs
Largest company Hawitt Pharmaceuticals Private Limited · ₹1.48 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Feb 20162016₹1.48 Cr (FY 2025)Active

Board colleagues of Rajesh Choudhary

NameDINCompanyDesignation
Aneesh Sharma07641152Hawitt Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hawitt Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajesh Choudhary

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Choudhary

Rajesh Choudhary currently holds 1 directorship: Hawitt Pharmaceuticals Private Limited (Director, since 10 Feb 2016, revenue ₹1.48 Cr (FY 2025)).

Rajesh Choudhary was first appointed on 10 Feb 2016 as Director at Hawitt Pharmaceuticals Private Limited.

The current boards of Rajesh Choudhary's companies include Aneesh Sharma (Hawitt Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available